Lastly, the manufacturing focus needs to shift from volume-based planning to demand-based planning, especially with the planned increased indications and patient access
Corrales FJ, Perez-Mato I, Sanchez del Pino MM, Ruiz F, Castro C, Garcia-Trevijano ER, Latasa U, Martinez-Chantar ML, Martinez-Cruz A, Avila MA, Mato JM: Regulation of mammalian liver methionine adenosyltransferase
For most people, the risk of rare thyroid cancers is extremely low, and the primary focus should be on how weight loss and metabolic changes affect thyroid function and medication requirements
While tirzepatide does not undergo significant renal clearance, limited safety data exist in severe kidney disease
The bright and the dark sides of L-carnitine supplementation: a systematic review [PMID: 32958033] Laboratory literature summary: The bright and the dark sides of L-carnitine supplementation: a systematic review